MedPath

Time Window for Ischemic Stroke First Mobilization Effectiveness

Not Applicable
Conditions
Brain Ischemia
Stroke Rehabilitation
Interventions
Other: early rehabilitation
Registration Number
NCT03938311
Lead Sponsor
China Stroke Databank Center
Brief Summary

Early mobilization was thought to be effective in patients with acute ischemic stroke. As the essential component of stroke unit care, early mobilization has already been part of routine clinical practice. However, it is uncertain that which and when medical service focusing on functional recovery should be delivered after the emergency interventions for stroke. Besides, the optimal time window, for delivering early mobilization after acute ischemic stroke, has not been verified with strong evidence.

Detailed Description

The TIME Trial is a pragmatic, investigator-initiated, multi-center, randomized, 3-arm parallel group, clinical trial. This trial will be conducted in 57 general hospitals in mainland China affiliated with the China Stroke Databank Center and will enroll 6033 eligible patients with acute ischemic stroke. Participants will be randomly allocated to either (1) the very early mobilization group in whichmobilization is initiated within 24 hours from stroke onset, (2) the early mobilization group in which mobilization begins between 24 and 72 hours poststroke, or (3) the late mobilization group in which mobilization is started after 72 hours poststroke. The mobilization protocol is otherwise standardized and identical for each comparison group. Mobilization is titrated by baseline mobility level and progress of patients throughout the intervention period. The primary outcome is death or disability assessed with the modified Rankin scale at 3 months poststroke. Secondary outcomes include impairment score of the National Institutes of Health Stroke Scale, dependence in activities of daily living as measured using the modified Barthel Index, cognitive ability assessed with the Mini-Mental State Examination, incidence of adverse events, hospital length of stay, and total medical costs.

Study design: an Investigator-Initiated Prospective Multicenter Randomized 3-Arm Clinical Trial

Sample size: 1500 cases

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • 1 diagnosed with ischemic stroke through anamnesis, clinical symptoms, and radiographic assessment;
  • 2 aged 18 years or older;
  • 3 of ischemic stroke within 12 hours before eligibility check;
  • 4 able to verbally respond to the instructions;
  • 5 with stable vital signs (systolic blood pressure 120-180 mmHg, heart rate 50-100/min, body temperature <37.5◦C, blood oxygen saturation >92%)
  • 6MMSE score > 16;
  • 7participation in the TIME Trial and sign the consent form.
Exclusion Criteria
  • 1 diagnosed with hemorrhagic stroke;
  • 2 NIHSS score < 2;
  • 3 pre-morbid modified Ranking Scale (mRS) score of 3-5;
  • 4 refusing randomization;
  • 5 having severe limb dysfunction or systemic diseases rendering them unable to cooperate in the mobilization intervention;
  • 6 having severe cognitive and mental dysfunctions;
  • 7 currently enrolled in another trial or having participated in a clinical trial within 6 months before stroke onset.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
late mobilization groupearly rehabilitationearly mobilization initiates after 72h from the onset of the disease
relative early rehabilitationearly rehabilitationearly mobilization initiates between 24-72h from the onset of the disease
very early rehabilitationearly rehabilitationearly mobilization initiates within 24h from the onset of the disease
Primary Outcome Measures
NameTimeMethod
modified Rankin Scale3 months after the cerebrovascular accident/or the last time appeared normally

modified Rankin Scale, to evaluate a subject's disability status. It's a rating data. The degrees range from 0 to 6, higher values represent a worse outcome and severe disability.

Secondary Outcome Measures
NameTimeMethod
Barthel Indexthe total score of Barthel Index will be recorded 15days、1month、3 months、6months after the cerebrovascular accident/or the last time appeared normally

ability of daily living, total scores range from 0 to 100, higher values represent a better outcome and independent living ability.

modified Rankin Scalethe total score of mRS will be recorded 15days、1month、6months after the cerebrovascular accident/or the last time appeared normally

modified Rankin Scale, to evaluate a subject's disability status. It's a rating data. The degrees range from 0 to 6, higher values represent a worse outcome and severe disability.

MMSEthe total score of MMSE will be recorded 15days、1month、3 months、6months after the cerebrovascular accident/or the last time appeared normally

Mini-mental State Examination. To evaluate a subject's mental state.The total score range from 0 to 30, higher values represent a better outcome.

NIHSS scoresthe total score of NIHSS will be recorded15days、1month、6months after the cerebrovascular accident/or the last time appeared normally

National Institute of Health stroke scale,total scores range from 0 to 42, higher values represent a better outcome.

Incidence of important medical eventsThe incidence of important medical events will be recorded 15days、1month、3 months after the cerebrovascular accident/or the last time appeared normally

falls, trauma, fracture, syncope, epilepsy, pneumonia, atelectasis, venous thrombosis, pulmonary embolism, pressure sores, death, etc.

Hospital LOSHospital LOS will be recorded 3 months after the cerebrovascular accident/or the last time appeared normally

length of stay in the acute hospital and in the rehabilitation hospital, and total hospital length of stay

Total medical costmedical cost will be recorded 3 months after the cerebrovascular accident/or the last time appeared normally

addition of the cost of each admission of the acute hospital and the rehabilitation hospital

Trial Locations

Locations (1)

the First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital)

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath